Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung ...
Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...
Add Yahoo as a preferred source to see more of our stories on Google. CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the ...
Multidisciplinary evaluation, including thoracic surgical consultation, is crucial for oligometastatic NSCLC patients to optimize treatment strategies. Lung surgery for oligometastatic NSCLC shows ...
Robotic and video-assisted thoracic surgery have revolutionized lung cancer treatment, minimizing trauma and shortening recovery times. Minimally invasive techniques enable complex procedures, ...
The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies ...
Researchers have discovered that aging may fundamentally reshape how lung cancer spreads. A stress-response protein called ...
Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...